All In Biotech

Drug Trial Radar · NCT07266441

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

168

Actual

Start

Feb 8, 2026

Primary completion

Jun 14, 2027

Study completion Dec 12, 2028

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Dec 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells called a plasma cell. Cancer is called relapsed if it comes back after treatment and is called 'refractory' if does not respond to treatment) who have received at least 3 prior lines of therapy.

Conditions

  • Multiple Myeloma

Interventions

  • JNJ-79635322Drug

    JNJ-79635322 will be administered as an injection under the skin.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: Up to 2 years and 9 months

Locations

71 sites in 8 countries. Site status is shown where the registry gives one.

  • O Neal Comprehensive Cancer Center at UAB

    Birmingham, Alabama

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • City of Hope

    Duarte, California

  • City of Hope Orange County Lennar Foundation Cancer Center

    Irvine, California

  • Cancer and Blood Specialty Clinic

    Los Alamitos, California

  • University of California San Francisco

    San Francisco, California

  • Rocky Mountain Cancer Centers

    Aurora, Colorado

  • Colorado Blood Cancer Institute

    Denver, Colorado

  • Cancer Specialists of North Florida

    Jacksonville, Florida

  • Emory University

    Atlanta, Georgia

  • Northside Hospital Cancer Institute

    Atlanta, Georgia

  • Cancer Care Specialists of Central Illinois

    O'Fallon, Illinois

  • University of Iowa

    Iowa City, Iowa

  • Mission Cancer Blood

    Waukee, Iowa

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Rutgers Cancer Institute

    New Brunswick, New Jersey

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Cleveland Clinic Foundtation

    Cleveland, Ohio

  • Oncology Associates of Oregon PC Willamette Valley Cancer Institute

    Eugene, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • SCRI Oncology Partners

    Nashville, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Texas Oncology

    Austin, Texas

  • MD Anderson Cancer Center

    Houston, Texas

  • Oncology Consultants Texas

    Houston, Texas

  • Texas Oncology - Northeast

    Tyler, Texas

  • Virginia Cancer Specialists

    Fairfax, Virginia

  • Virginia Oncology Associates

    Norfolk, Virginia

  • NorthWest Medical Specialties, PLLC

    Tacoma, Washington

  • Peking Union Medical College Hospital

    Beijing, China

  • Beijing Chaoyang Hospital

    Chaoyang District, China

  • Sun Yat Sen University Cancer Center

    Guangzhou, China

  • Shanghai Fourth People s Hospital

    Shanghai, China

  • Ha'Emek Medical Center

    Afula, Israel

  • Samson Assuta Ashdod University Hospital

    Ashdod, Israel

  • Hillel Yaffe Medical Center

    Hadera, Israel

  • Hadassah Medical Center

    Jerusalem, Israel

  • Rabin Medical Center

    Petah Tikva, Israel

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

Showing 40 of 71 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.